Senzime AB (publ)

SSE:SEZI.ST

7.25 (SEK) • At close February 20, 2024
Bedrijfsnaam Senzime AB (publ)
Symbool SEZI.ST
Munteenheid SEK
Prijs 7.25
Beurswaarde 673,380,247
Dividendpercentage 0%
52-weken bereik 2.605 - 8.46
Industrie Medical Devices
Sector Healthcare
CEO Mr. Philip Siberg
Website https://senzime.com

An error occurred while fetching data.

Over Senzime AB (publ)

Senzime AB (publ), a medical device company, develops and markets patient monitoring systems to monitor patients under anesthesia in Europe, Oceania, Asia, Canada, and the United States. The company offers TetraGraph, a monitor that stimulates, measures, analyzes, and displays muscle function in surgical patients receiving neuromuscular blocking agents; TetraSens electrode

Vergelijkbare Aandelen

Xspray Pharma AB (publ) logo

Xspray Pharma AB (publ)

XSPRAY.ST

44 SEK

ADDvise Group AB (publ) logo

ADDvise Group AB (publ)

ADDV-A.ST

11.6 SEK

Diamyd Medical AB (publ) logo

Diamyd Medical AB (publ)

DMYD-B.ST

13.3 SEK

Cantargia AB (publ) logo

Cantargia AB (publ)

CANTA.ST

3.32 SEK

C-Rad AB (publ) logo

C-Rad AB (publ)

CRAD-B.ST

46.55 SEK

Isofol Medical AB (publ) logo

Isofol Medical AB (publ)

ISOFOL.ST

0.616 SEK

Biovica International AB (publ) logo

Biovica International AB (publ)

BIOVIC-B.ST

2.34 SEK

Paxman AB (publ) logo

Paxman AB (publ)

PAX.ST

38.6 SEK

Infant Bacterial Therapeutics AB (publ) logo

Infant Bacterial Therapeutics AB (publ)

IBT-B.ST

93.4 SEK

Financiële Gegevens

Cijfers zijn in miljoenen (SEK)

Cijfers zijn in miljoenen (SEK)